Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 15
Original Research
Assessing the Health Economic Outcomes from Commercially Insured Relapsing Multiple Sclerosis Patients Who Switched from Other Disease-Modifying Therapies to Teriflunomide, in the United States
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 2,996 | Dovepress* | 2,924+ | 68 | 2,992 | |
| PubMed Central* | 72 | 42 | 114 | ||
| Totals | 2,996 | 110 | 3,106 | ||
| *Since 20 May 2023 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar